Catalyst Wire Dossier Catalyst Wire Dossier

paritaprevir/ombitasvir

paritaprevir/ombitasvir · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for paritaprevir/ombitasvir, covering 2019-10-11 to 2019-10-11. Get the full timeline:

Most recent: Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

See pricing